Global HER2 Antibodies Market Status and Growth Report at a CAGR of 8.6% During 2017–2025
HER2 breast cancer is one of the hostile types of breast cancer, caused due to over-expression of the HER2 protein. It has been analyzed that being overweight, long term heavy smoking, use of menopausal hormone therapy, physical inactivity and alcohol consumption are seen as the prime factors responsible for increasing risk of breast cancer. Such a scenario has led to the rise in demand for HER2 prevention therapies and antibodies. To study further, a new report has been included in...
View full press release